O117 : Predictors of clinical response: Results from a large, randomized controlled study with tenofovir disoproxil fumarate (TDF) plus peginterferon alfa-2A (PEG) combination for chronic hepatitis B (CHB)
Chan, H.L., Ahn, S.H., Chuang, W.L., Hui, A.J., Tabak, F., Mehta, R., Petersen, J., Lee, C.-M., Ma, X., Caruntu, F.A., Tak, W.Y., Elkhashab, M., Lin, L., Dinh, P., Martins, E.B., Charuworn, P., McHutcVolume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30136-7
Date:
April, 2015
File:
PDF, 189 KB
english, 2015
File converter
More search results
More benefits 
